Eagle Pharmaceuticals to Host Second Quarter 2021 Financial Results on August 9, 2021
Eagle Pharmaceuticals (Nasdaq: EGRX) announced the release of its Q2 2021 financial results on August 9, 2021, prior to market opening. CEO Scott Tarriff and CFO Brian Cahill will lead a conference call at 8:30 a.m. ET to discuss the results. Participation details include toll-free numbers for U.S. and international callers and a webcast available for replay. The company focuses on innovative medicines with products like RYANODEX®, BENDEKA®, and BELRAPZO®. Additional information is available on their website.
- Eagle Pharmaceuticals has established a diverse product pipeline with innovative medicines.
- The company is committed to improving patient outcomes through its research and development efforts.
- None.
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2021 second quarter financial results on Monday, August 9, 2021, before the market opens.
Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will host a conference call to discuss the results as follows:
Date |
Monday, August 9, 2021 |
||
Time |
8:30 a.m. ET |
||
Toll free (U.S.) |
877-876-9173 |
||
International |
785-424-1667 |
||
Webcast (live and replay) |
www.eagleus.com, under the “Investor Relations” section |
A replay of the conference call will be available for one week after the call's completion by dialing 888-562-2815 (US) or 402-220-7352 (International) and entering conference call ID EGRXQ221. The webcast will be archived for 30 days at the aforementioned URL.
About Eagle Pharmaceuticals, Inc.
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210728006015/en/
FAQ
When will Eagle Pharmaceuticals release its Q2 2021 financial results?
What time will the Eagle Pharmaceuticals conference call take place?
How can I access the Eagle Pharmaceuticals conference call replay?
What products does Eagle Pharmaceuticals have?
